Business Standard

Monday, December 30, 2024 | 11:03 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

RPG Life Sciences zooms 20% as PBT jumps four-fold in Q2

Meanwhile, operational revenue during the quarter grew 8.8 per cent at Rs 98.49 crore, as against Rs 90.5 crore in the corresponding quarter of the previous year.

Pharma
Premium

SI Reporter Mumbai
Shares of RPG Life Sciences were locked in the upper circuit band of 20 per cent at Rs 255 on the BSE on Thursday after the company’s profit before tax (PBT) jumped four-fold to Rs 12.04 crore in the September quarter of FY20 (Q2FY20). The company, engaged in manufacturing and marketing of pharmaceutical products, had a PBT of Rs 3.1 crore in the year ago quarter.

Meanwhile, operational revenue during the quarter grew 8.8 per cent at Rs 98.49 crore, as against Rs 90.5 crore in the corresponding quarter of the previous year. EBITDA (earnings before interest, tax, depreciation and amortisation)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in